HEADER TRANSFERASE 09-MAY-23 8P04 TITLE CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH LEUCETTINIB-92 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDC-LIKE KINASE 1; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK1, CLK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TYP1 INHIBITOR, CLK1, LEICETTINIB, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.KRAEMER,M.SCHROEDER,L.MEIJER,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 3 22-NOV-23 8P04 1 JRNL REVDAT 2 24-MAY-23 8P04 1 REMARK HET ATOM REVDAT 1 17-MAY-23 8P04 0 JRNL AUTH E.DEAU,M.F.LINDBERG,F.MIEGE,D.ROCHE,N.GEORGE,P.GEORGE, JRNL AUTH 2 A.KRAMER,S.KNAPP,L.MEIJER JRNL TITL LEUCETTINIBS, A CLASS OF DYRK/CLK KINASE INHIBITORS INSPIRED JRNL TITL 2 BY THE MARINE SPONGE NATURAL PRODUCT LEUCETTAMINE B. JRNL REF J.MED.CHEM. V. 66 10694 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37487467 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00884 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 10693 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.550 REMARK 3 FREE R VALUE TEST SET COUNT : 807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.7200 - 3.7500 0.93 1603 147 0.1824 0.2418 REMARK 3 2 3.7500 - 3.2800 0.96 1665 130 0.2065 0.2470 REMARK 3 3 3.2800 - 2.9800 0.95 1621 144 0.2240 0.3289 REMARK 3 4 2.9800 - 2.7600 0.96 1666 131 0.2291 0.2692 REMARK 3 5 2.7600 - 2.6000 0.97 1681 119 0.2479 0.2935 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : 0.043 397 REMARK 3 PLANARITY : 0.004 468 REMARK 3 DIHEDRAL : 5.753 371 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8P04 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1292130345. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10715 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 46.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.2 SODIUM MALONATE PH7, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.06700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.01300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.06700 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.01300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 146 REMARK 465 TYR A 305 REMARK 465 ASN A 306 REMARK 465 PRO A 307 REMARK 465 LYS A 308 REMARK 465 ILE A 309 REMARK 465 LYS A 310 REMARK 465 ARG A 311 REMARK 465 ASP A 312 REMARK 465 HIS A 335 REMARK 465 HIS A 336 REMARK 465 SER A 337 REMARK 465 THR A 338 REMARK 465 LEU A 339 REMARK 465 VAL A 340 REMARK 465 LYS A 482 REMARK 465 SER A 483 REMARK 465 ILE A 484 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 147 CB CG SD CE REMARK 470 HIS A 148 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 186 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 198 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 201 CG CD OE1 OE2 REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 208 CG CD OE1 NE2 REMARK 470 GLU A 211 CG CD OE1 OE2 REMARK 470 LYS A 274 CE NZ REMARK 470 LYS A 283 CD CE NZ REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 GLU A 313 CG CD OE1 OE2 REMARK 470 ASP A 333 CG OD1 OD2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 SER A 341 OG REMARK 470 THR A 342 OG1 CG2 REMARK 470 ARG A 343 NE CZ NH1 NH2 REMARK 470 ARG A 346 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 393 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 ARG A 407 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 410 CG CD CE NZ REMARK 470 ARG A 416 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 420 CG OD1 OD2 REMARK 470 ARG A 427 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 437 CG CD CE NZ REMARK 470 GLN A 443 CG CD OE1 NE2 REMARK 470 LYS A 464 CE NZ REMARK 470 ARG A 469 CD NE CZ NH1 NH2 REMARK 470 LYS A 481 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 151 45.41 -165.27 REMARK 500 ARG A 160 -19.61 -166.56 REMARK 500 ALA A 183 48.49 -154.66 REMARK 500 THR A 287 -9.92 68.40 REMARK 500 GLN A 298 -44.81 67.74 REMARK 500 ILE A 317 -78.08 -98.44 REMARK 500 ASP A 325 96.19 67.05 REMARK 500 THR A 342 160.57 175.17 REMARK 500 ARG A 343 -100.34 -150.85 REMARK 500 SER A 357 -148.28 -151.92 REMARK 500 PHE A 379 66.31 -119.29 REMARK 500 LYS A 408 49.51 -74.77 REMARK 500 ARG A 409 9.12 -69.64 REMARK 500 HIS A 414 -123.54 62.41 REMARK 500 LEU A 458 32.65 -92.89 REMARK 500 REMARK 500 REMARK: NULL DBREF 8P04 A 148 484 UNP P49759 CLK1_HUMAN 148 484 SEQADV 8P04 SER A 146 UNP P49759 EXPRESSION TAG SEQADV 8P04 MET A 147 UNP P49759 EXPRESSION TAG SEQADV 8P04 ALA A 432 UNP P49759 ARG 432 CONFLICT SEQRES 1 A 339 SER MET HIS LEU ILE CYS GLN SER GLY ASP VAL LEU SER SEQRES 2 A 339 ALA ARG TYR GLU ILE VAL ASP THR LEU GLY GLU GLY ALA SEQRES 3 A 339 PHE GLY LYS VAL VAL GLU CYS ILE ASP HIS LYS ALA GLY SEQRES 4 A 339 GLY ARG HIS VAL ALA VAL LYS ILE VAL LYS ASN VAL ASP SEQRES 5 A 339 ARG TYR CYS GLU ALA ALA ARG SER GLU ILE GLN VAL LEU SEQRES 6 A 339 GLU HIS LEU ASN THR THR ASP PRO ASN SER THR PHE ARG SEQRES 7 A 339 CYS VAL GLN MET LEU GLU TRP PHE GLU HIS HIS GLY HIS SEQRES 8 A 339 ILE CYS ILE VAL PHE GLU LEU LEU GLY LEU SER THR TYR SEQRES 9 A 339 ASP PHE ILE LYS GLU ASN GLY PHE LEU PRO PHE ARG LEU SEQRES 10 A 339 ASP HIS ILE ARG LYS MET ALA TYR GLN ILE CYS LYS SER SEQRES 11 A 339 VAL ASN PHE LEU HIS SER ASN LYS LEU THR HIS THR ASP SEQRES 12 A 339 LEU LYS PRO GLU ASN ILE LEU PHE VAL GLN SER ASP TYR SEQRES 13 A 339 THR GLU ALA TYR ASN PRO LYS ILE LYS ARG ASP GLU ARG SEQRES 14 A 339 THR LEU ILE ASN PRO ASP ILE LYS VAL VAL ASP PHE GLY SEQRES 15 A 339 SER ALA THR TYR ASP ASP GLU HIS HIS SER THR LEU VAL SEQRES 16 A 339 SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU ALA SEQRES 17 A 339 LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE GLY SEQRES 18 A 339 CYS ILE LEU ILE GLU TYR TYR LEU GLY PHE THR VAL PHE SEQRES 19 A 339 PRO THR HIS ASP SER LYS GLU HIS LEU ALA MET MET GLU SEQRES 20 A 339 ARG ILE LEU GLY PRO LEU PRO LYS HIS MET ILE GLN LYS SEQRES 21 A 339 THR ARG LYS ARG LYS TYR PHE HIS HIS ASP ARG LEU ASP SEQRES 22 A 339 TRP ASP GLU HIS SER SER ALA GLY ARG TYR VAL SER ARG SEQRES 23 A 339 ALA CYS LYS PRO LEU LYS GLU PHE MET LEU SER GLN ASP SEQRES 24 A 339 VAL GLU HIS GLU ARG LEU PHE ASP LEU ILE GLN LYS MET SEQRES 25 A 339 LEU GLU TYR ASP PRO ALA LYS ARG ILE THR LEU ARG GLU SEQRES 26 A 339 ALA LEU LYS HIS PRO PHE PHE ASP LEU LEU LYS LYS SER SEQRES 27 A 339 ILE HET WAK A 501 27 HETNAM WAK (4~{Z})-2-(1-ADAMANTYLAMINO)-4-(1,3-BENZOTHIAZOL-6- HETNAM 2 WAK YLMETHYLIDENE)-1~{H}-IMIDAZOL-5-ONE FORMUL 2 WAK C21 H22 N4 O S FORMUL 3 HOH *5(H2 O) HELIX 1 AA1 MET A 147 CYS A 151 5 5 HELIX 2 AA2 LYS A 182 GLY A 184 5 3 HELIX 3 AA3 VAL A 196 ASP A 217 1 22 HELIX 4 AA4 SER A 247 ASN A 255 1 9 HELIX 5 AA5 ARG A 261 SER A 281 1 21 HELIX 6 AA6 LYS A 290 GLU A 292 5 3 HELIX 7 AA7 ALA A 347 LEU A 352 1 6 HELIX 8 AA8 GLN A 358 GLY A 375 1 18 HELIX 9 AA9 ASP A 383 GLY A 396 1 14 HELIX 10 AB1 PRO A 399 GLN A 404 1 6 HELIX 11 AB2 LYS A 408 LYS A 410 5 3 HELIX 12 AB3 SER A 423 CYS A 433 1 11 HELIX 13 AB4 PRO A 435 MET A 440 5 6 HELIX 14 AB5 ASP A 444 LEU A 458 1 15 HELIX 15 AB6 THR A 467 LEU A 472 1 6 HELIX 16 AB7 LYS A 473 ASP A 478 5 6 SHEET 1 AA1 6 VAL A 156 LEU A 157 0 SHEET 2 AA1 6 TYR A 161 GLU A 169 -1 O TYR A 161 N LEU A 157 SHEET 3 AA1 6 GLY A 173 ASP A 180 -1 O GLU A 177 N VAL A 164 SHEET 4 AA1 6 HIS A 187 VAL A 193 -1 O ILE A 192 N LYS A 174 SHEET 5 AA1 6 HIS A 236 GLU A 242 -1 O PHE A 241 N ALA A 189 SHEET 6 AA1 6 MET A 227 HIS A 233 -1 N GLU A 229 O VAL A 240 SHEET 1 AA2 2 LEU A 284 THR A 285 0 SHEET 2 AA2 2 THR A 330 TYR A 331 -1 O THR A 330 N THR A 285 SHEET 1 AA3 2 ILE A 294 PHE A 296 0 SHEET 2 AA3 2 ILE A 321 VAL A 323 -1 O LYS A 322 N LEU A 295 SHEET 1 AA4 2 PHE A 412 HIS A 413 0 SHEET 2 AA4 2 ARG A 416 LEU A 417 -1 O ARG A 416 N HIS A 413 CRYST1 92.134 64.026 70.571 90.00 118.49 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010854 0.000000 0.005891 0.00000 SCALE2 0.000000 0.015619 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016123 0.00000